203 related articles for article (PubMed ID: 32920767)
1. Randomized Clinical Trial on Reduction of Radiotherapy Dose to the Elective Neck in Head and Neck Squamous Cell Carcinoma: Results on the Quality of Life.
Deschuymer S; Nevens D; Duprez F; Daisne JF; Voordeckers M; De Neve W; Nuyts S
Qual Life Res; 2021 Jan; 30(1):117-127. PubMed ID: 32920767
[TBL] [Abstract][Full Text] [Related]
2. Randomized clinical trial on reduction of radiotherapy dose to the elective neck in head and neck squamous cell carcinoma; update of the long-term tumor outcome.
Deschuymer S; Nevens D; Duprez F; Daisne JF; Dok R; Laenen A; Voordeckers M; De Neve W; Nuyts S
Radiother Oncol; 2020 Feb; 143():24-29. PubMed ID: 32044165
[TBL] [Abstract][Full Text] [Related]
3. Quality-of-life (QOL) outcomes in patients with head and neck squamous cell carcinoma (HNSCC) treated with intensity-modulated radiation therapy (IMRT) compared to three-dimensional conformal radiotherapy (3D-CRT): evidence from a prospective randomized study.
Rathod S; Gupta T; Ghosh-Laskar S; Murthy V; Budrukkar A; Agarwal J
Oral Oncol; 2013 Jun; 49(6):634-42. PubMed ID: 23562564
[TBL] [Abstract][Full Text] [Related]
4. Reduction of the dose of radiotherapy to the elective neck in head and neck squamous cell carcinoma; a randomized clinical trial. Effect on late toxicity and tumor control.
Nevens D; Duprez F; Daisne JF; Dok R; Belmans A; Voordeckers M; Van den Weyngaert D; De Neve W; Nuyts S
Radiother Oncol; 2017 Feb; 122(2):171-177. PubMed ID: 27528118
[TBL] [Abstract][Full Text] [Related]
5. An international phase 3 trial in head and neck cancer: quality of life and symptom results: EORTC 24954 on behalf of the EORTC Head and Neck and the EORTC Radiation Oncology Group.
Bottomley A; Tridello G; Coens C; Rolland F; Tesselaar ME; Leemans CR; Hupperets P; Licitra L; Vermorken JB; Van Den Weyngaert D; Truc G; Barillot I; Lefebvre JL
Cancer; 2014 Feb; 120(3):390-8. PubMed ID: 24452673
[TBL] [Abstract][Full Text] [Related]
6. Reduction of the dose to the elective neck in head and neck squamous cell carcinoma, a randomized clinical trial using intensity modulated radiotherapy (IMRT). Dosimetrical analysis and effect on acute toxicity.
Nuyts S; Lambrecht M; Duprez F; Daisne JF; Van Gestel D; Van den Weyngaert D; Platteaux N; Geussens Y; Voordeckers M; Madani I; De Neve W
Radiother Oncol; 2013 Nov; 109(2):323-9. PubMed ID: 23953410
[TBL] [Abstract][Full Text] [Related]
7. Pretreatment quality of life as a prognostic factor for early survival and functional outcomes in patients with head and neck cancer.
Yang CJ; Roh JL; Kim MJ; Lee SW; Kim SB; Choi SH; Nam SY; Kim SY
Qual Life Res; 2016 Jan; 25(1):165-74. PubMed ID: 26156405
[TBL] [Abstract][Full Text] [Related]
8. Health-related quality of life in 640 head and neck cancer survivors after radiotherapy using EORTC QLQ-C30 and QLQ-H&N35 questionnaires.
Wan Leung S; Lee TF; Chien CY; Chao PJ; Tsai WL; Fang FM
BMC Cancer; 2011 Apr; 11():128. PubMed ID: 21486431
[TBL] [Abstract][Full Text] [Related]
9. Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial.
Harrington KJ; Ferris RL; Blumenschein G; Colevas AD; Fayette J; Licitra L; Kasper S; Even C; Vokes EE; Worden F; Saba NF; Kiyota N; Haddad R; Tahara M; Grünwald V; Shaw JW; Monga M; Lynch M; Taylor F; DeRosa M; Morrissey L; Cocks K; Gillison ML; Guigay J
Lancet Oncol; 2017 Aug; 18(8):1104-1115. PubMed ID: 28651929
[TBL] [Abstract][Full Text] [Related]
10. Changes in quality of life of head-and-neck cancer patients following postoperative radiotherapy.
Fang FM; Chien CY; Kuo SC; Chiu HC; Wang CJ
Acta Oncol; 2004; 43(6):571-8. PubMed ID: 15370615
[TBL] [Abstract][Full Text] [Related]
11. The impact of radiotherapy on the quality of life in patients with early-stage clinical head and neck cancer.
Milecki J; Żmijewska-Tomczak M; Osmola K; Wierzbicka M
Otolaryngol Pol; 2021 May; 75(5):1-8. PubMed ID: 34552020
[TBL] [Abstract][Full Text] [Related]
12. Quantitative analysis of normal tissue effects in the clinic (QUANTEC) guideline validation using quality of life questionnaire datasets for parotid gland constraints to avoid causing xerostomia during head-and-neck radiotherapy.
Lee TF; Fang FM
Radiother Oncol; 2013 Mar; 106(3):352-8. PubMed ID: 23333019
[TBL] [Abstract][Full Text] [Related]
13. Parotid gland sparing with helical tomotherapy in head-and-neck cancer.
Voordeckers M; Farrag A; Everaert H; Tournel K; Storme G; Verellen D; De Ridder M
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):443-8. PubMed ID: 22836056
[TBL] [Abstract][Full Text] [Related]
14. Single-Arm Phase 2 Trial of Elective Nodal Dose Reduction for Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck.
Maguire PD; Neal CR; Hardy SM; Schreiber AM
Int J Radiat Oncol Biol Phys; 2018 Apr; 100(5):1210-1216. PubMed ID: 29452770
[TBL] [Abstract][Full Text] [Related]
15. Quality of life, HPV-status and phase angle predict survival in head and neck cancer patients under (chemo)radiotherapy undergoing nutritional intervention: Results from the prospective randomized HEADNUT-trial.
Kutz LM; Abel J; Schweizer D; Tribius S; Krüll A; Petersen C; Löser A
Radiother Oncol; 2022 Jan; 166():145-153. PubMed ID: 34838889
[TBL] [Abstract][Full Text] [Related]
16. Quality of life in patients with oropharynx carcinomas: assessment after accelerated radiotherapy with or without chemotherapy versus radical surgery and postoperative radiotherapy.
Allal AS; Nicoucar K; Mach N; Dulguerov P
Head Neck; 2003 Oct; 25(10):833-9; discussion 839-40. PubMed ID: 12966507
[TBL] [Abstract][Full Text] [Related]
17. Changing quality of life in patients with advanced head and neck cancer after primary radiotherapy or chemoradiation.
Fang FM; Tsai WL; Chien CY; Chiu HC; Wang CJ; Chen HC; Hsiung CY
Oncology; 2005; 68(4-6):405-13. PubMed ID: 16020970
[TBL] [Abstract][Full Text] [Related]
18. High-dose-rate interstitial brachytherapy in oral cancer-Its impact on quality of life.
Bajwa HK; Singareddy R; Alluri KR
Brachytherapy; 2016; 15(3):381-386. PubMed ID: 26947320
[TBL] [Abstract][Full Text] [Related]
19. Quality of life in long-term survivors of oropharynx carcinoma.
Pourel N; Peiffert D; Lartigau E; Desandes E; Luporsi E; Conroy T
Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):742-51. PubMed ID: 12377326
[TBL] [Abstract][Full Text] [Related]
20. Explorative study on quality of life in relation to salivary secretion rate in patients with head and neck cancer treated with radiotherapy.
Almståhl A; Alstad T; Fagerberg-Mohlin B; Carlén A; Finizia C
Head Neck; 2016 May; 38(5):782-91. PubMed ID: 25537660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
